Quantum-Si incorporated

NasdaqGM QSI

Quantum-Si incorporated EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -4,111.12%

Quantum-Si incorporated EBIT Margin is -4,111.12% for the Trailing 12 Months (TTM) ending September 30, 2024, a 76.10% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Quantum-Si incorporated EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -17,203.23%.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NasdaqGM: QSI

Quantum-Si incorporated

CEO	Mr. Jeffrey Alan Hawkins
IPO Date	Nov. 13, 2020
Location	United States
Headquarters	530 Old Whitfield Street
Employees	159
Sector	Health Care
Industries Biotechnology Pharmaceuticals Semiconductors

Description

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Key trends

Past 5 years